First Real-World Observational Study of the JADA System, a M

14.09.2023 - Organon (NYSE: OGN), a global healthcare company focused on improving women’s health, today announced that Obstetrics & Gynecology (“The Green Journal”), the peer-reviewed journal of the American College of Obstetrics and Gynecology (ACOG), ...

Related Keywords

Jersey City , New Jersey , United States , New York , Maryland , Dena Goffman , Thromb Haemost , Patricia Carney , Carvalho Pacagnella , Centers For Disease , Instagram , Columbia University Irving Medical Center , Organon Medical Affairs , Safe Motherhood Initiative , Womens Health , Facebook , Department Of Obstetrics , World Health Organisation , Agency For Healthcare Research , Organon Company Stock , Exchange Commission , Twitter , Glob Health , Society For Maternal , Linkedin , Treating Abnormal Postpartum Uterine Bleeding , Postpartum Hemorrhage , Maternal Fetal Medicine , Annual Pregnancy Meeting , Post Hoc Analysis Supports Appropriate Control , Loss Thresholds Prior , Cumulative Blood Loss Prior , Securities Litigation Reform , Annual Report , Ejada System , Prev Med , Maternal Morbidity , Updated July , Care Consensus , Obstetric Hemorrhage , Accessed April , Van Hook , Updated February , Market Registry , Disease Control , Healthcare Research , Company Stock , Organon Company Chart , Rganon Company Kurs , Rganon Company Aktie ,